Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

PeptiDream

Biotech & Life Sciences · Tokyo, Japan · Founded 2006 · IPO 2013 Unicorn

Proprietary peptide discovery platform for therapeutic development

Valuation
$1.06B
Market cap · May/2026
Revenue
$139M
Latest reported FY
EBITDA
$180M
Latest reported FY

Investors

2 investors on PeptiDream's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
Novartis
The University of Tokyo

Global footprint

Where PeptiDream has talent and traffic

Workforce by country
🇯🇵 Japan · Tokyo HQ
Book a demo for the full country breakdown
Web traffic by country
34K monthly visits
across markets
🇯🇵 Japan90.9%
🇺🇸 United States7.9%
🏳️ Korea2.6%
🏳️ Republic of0.3%
🇬🇧 United Kingdom0%
Top 5 markets shown

Patent intelligence

$28M patent portfolio · 100 active families

Estimated portfolio value
$28M
2.7% of market cap · 36.7× the top peer iCarbonX ($767k)
100 active patent families
Where PeptiDream innovates Computer scienceComputer programImaging dataImaging processingRecording media

Where PeptiDream concentrates vs peers

Each axis is a top-10 topic across PeptiDream and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

PeptiDream's 4 investments and acquisitions.

Every disclosed deal where PeptiDream appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across PeptiDream's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where PeptiDream deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        PeptiDream's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about PeptiDream

        An AI-synthesized read of the highest-engagement posts about PeptiDream on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See PeptiDream on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.